A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen.
Chiwala G, Liu Z, Mugweru JN, Wang B, Khan SA, Bate PNN, Yusuf B, Hameed HMA, Fang C, Tan Y, Guan P, Hu J, Tan S, Liu J, Zhong N, Zhang T.
Chiwala G, et al. Among authors: bate pnn.
Biomed Pharmacother. 2021 Oct;142:112047. doi: 10.1016/j.biopha.2021.112047. Epub 2021 Aug 21.
Biomed Pharmacother. 2021.
PMID: 34426260
Free article.